GENTIAN DIAGNOSTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 54 NOK | +20.00% |
|
+28.57% | +30.12% |
| 30/04 | Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 30/04 | Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Diagnostic & Testing Substances
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 78.15M | ||||||
| 11.24B | ||||||
| 7.29B | ||||||
| 5.57B | - | - | ||||
| 3.68B | ||||||
| 2.58B | - | - | - | - | - |
- Stock Market
- Equities
- GENT Stock
- Charts Gentian Diagnostics
- Sector Chart
